omeprazole has been researched along with Metabolic Syndrome in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gastroesophageal reflux disease is a common and chronic disorder but long term, prospective studies of the fate of patients seeking medical advice are scarce." | 1.34 | Prospective Acid Reflux Study of Iran (PARSI): methodology and study design. ( Abedi, B; Alimohamadi, SM; Ghotbi, MH; Malekzadeh, R; Mamarabadi, M; Mofid, A; Mostajabi, P; Nasseri-Moghaddam, S; Nouraie, M; Razjouyan, H; Sohrabpour, AA; Sotoudeh, M; Tofangchiha, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nasseri-Moghaddam, S | 1 |
| Razjouyan, H | 1 |
| Alimohamadi, SM | 1 |
| Mamarabadi, M | 1 |
| Ghotbi, MH | 1 |
| Mostajabi, P | 1 |
| Sohrabpour, AA | 1 |
| Sotoudeh, M | 1 |
| Abedi, B | 1 |
| Mofid, A | 1 |
| Nouraie, M | 1 |
| Tofangchiha, S | 1 |
| Malekzadeh, R | 1 |
1 other study available for omeprazole and Metabolic Syndrome
| Article | Year |
|---|---|
Prospective Acid Reflux Study of Iran (PARSI): methodology and study design.
Topics: Biopsy; Comorbidity; Drug Administration Schedule; Esophagogastric Junction; Esophagus; Feasibility | 2007 |